Moving Beyond Cell Surface Receptors: Advancing First-in-Class Tumour Microenvironment Targets into the Clinic

• Presenting the rationale for targeting the tumour microenvironment as a next-generation approach to radiopharmaceutical development
• Exploring the potential advantages of non-cell receptorbased targeting strategies in expanding patient eligibility and improving therapeutic flexibility
• Sharing lessons learned from advancing a first-in-class radiopharmaceutical programme through Phase 0 clinical evaluation

Speakers: